rxstat › Shortages › Chlorthalidone Azilsartan Medoxomil

Chlorthalidone Azilsartan Medoxomil (Edarbyclor) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Chlorthalidone Azilsartan Medoxomil has no current shortage reported in Canada. It has been in shortage before; the history is below.

A combination of a diuretic and an ARB used to lower high blood pressure.

Products affected

0 / 2

Reports on file

Shortage history

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved

EDARBYCLOR

12.5MG 40MG · TABLET · BAUSCH HEALTH, CANADA INC.

DIN 02397749 · ended Apr 8, 2025 · Missing/ Waiting on Documents from Supplier

Resolved

EDARBYCLOR

25MG 40MG · TABLET · BAUSCH HEALTH, CANADA INC.

DIN 02397765 · ended Mar 29, 2022 · Delay in shipping of the drug.

Resolved

EDARBYCLOR

12.5MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397749 · ended Apr 23, 2020 · Delay in shipping of the drug.

Resolved

EDARBYCLOR

12.5MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397749 · ended Jan 20, 2020 · delay in production

Resolved

EDARBYCLOR

25MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397765 · ended Nov 18, 2019 · supplier delay

Resolved

EDARBYCLOR

12.5MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397749 · ended Aug 2, 2019 · delay in production

Avoided

EDARBYCLOR

12.5MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397749 · ended May 21, 2019 · anticipated

Resolved

EDARBYCLOR

12.5MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397749 · ended Jan 22, 2019

Resolved

EDARBYCLOR

25MG 40MG · TABLET · VALEANT CANADA LP/VALEANT CANADA S.E.C.

DIN 02397765 · ended Nov 1, 2018

What's happening

There are no active shortage reports for Chlorthalidone Azilsartan Medoxomil. Health Canada has 9 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Chlorthalidone Azilsartan Medoxomil is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DA).

Recent changes

No changes recorded yet.

Common questions

What is Chlorthalidone Azilsartan Medoxomil used for?

A combination of a diuretic and an ARB used to lower high blood pressure.

When will Chlorthalidone Azilsartan Medoxomil be back in stock in Canada?

Chlorthalidone Azilsartan Medoxomil has no active shortage; supply is normal per Health Canada reports.

Why is Chlorthalidone Azilsartan Medoxomil in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (angiotensin ii antagonists, combinations)

Amlodipine Telmisartan (Twynsta) Partial shortage 2 of 6 reported products affected Hydrochlorothiazide Candesartan Cilexetil (Atacand Plus) Partial shortage 4 of 21 reported products affected · est. return Aug 31, 2026 Hydrochlorothiazide Losartan (Hyzaar) Partial shortage 2 of 35 reported products affected Hydrochlorothiazide Valsartan Partial shortage 5 of 27 reported products affected · est. return Jul 31, 2026 Irbesartan Hydrochlorothiazide (Avalide) Partial shortage 14 of 35 reported products affected · est. return Mar 3, 2027 Olmesartan Medoxomil Hydrochlorothiazide (Olmetec Plus) Partial shortage 6 of 24 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.